The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover,
- PDF / 854,187 Bytes
- 12 Pages / 595.276 x 790.866 pts Page_size
- 70 Downloads / 143 Views
ORIGINAL CONTRIBUTION
The effect of Nigella sativa supplementation on cardiovascular risk factors in obese and overweight women: a crossover, double‑blind, placebo‑controlled randomized clinical trial Elham Razmpoosh1,2,3 · Sara Safi1,2 · Azadeh Nadjarzadeh1,2 · Hossien Fallahzadeh4 · Nooshin Abdollahi1,2 · Mahta Mazaheri5,6 · Majid Nazari7 · Amin Salehi‑Abargouei1,2 Received: 31 March 2020 / Accepted: 19 August 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Purpose To assess the effect of Nigella sativa (N.S) oil supplements on CVD risk factors in a crossover design for the first time. Methods Obese and overweight healthy women were randomized to receive N.S oil (2000 mg/day) and placebo. This intervention period lasted for 8 weeks and separated by a 4-week washout period. An iso-caloric diet was given to every individual throughout the study. Blood pressure, lipid profile, atherogenic indices and liver enzymes were measured. Pkcross procedure was performed for statistical analyses using Stata software. Cohen’s d was estimated as effect size for all outcomes to measure the magnitude of the effects. Results Thirty-nine participants completed the study. Capsules of N.S increased serum high-density lipoprotein cholesterol (Cohen’s d = 0.47, P = 0.009), reduced low-density lipoprotein cholesterol (Cohen’s d = − 0.33, P = 0.031), reduced TC/ HDL-C ratio (as an atherogenic index, Cohen’s d = − 0.9, P
Data Loading...
